27 research outputs found
Perceptions of the Norwood Community regarding its existing educational system and possible amalgamation
77 leaves
Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies
Iatrogenic vascular air embolism is a relatively infrequent event but is associated with significant morbidity and mortality. These emboli can arise in many clinical settings such as neurosurgery, cardiac surgery, and liver transplantation, but more recently, endoscopy, hemodialysis, thoracentesis, tissue biopsy, angiography, and central and peripheral venous access and removal have overtaken surgery and trauma as significant causes of vascular air embolism. The true incidence may be greater since many of these air emboli are asymptomatic and frequently go undiagnosed or unreported. Due to the rarity of vascular air embolism and because of the many manifestations, diagnoses can be difficult and require immediate therapeutic intervention. An iatrogenic air embolism can result in both venous and arterial emboli whose anatomic locations dictate the clinical course. Most clinically significant iatrogenic air emboli are caused by arterial obstruction of small vessels because the pulmonary gas exchange filters the more frequent, smaller volume bubbles that gain access to the venous circulation. However, there is a subset of patients with venous air emboli caused by larger volumes of air who present with more protean manifestations. There have been significant gains in the understanding of the interactions of fluid dynamics, hemostasis, and inflammation caused by air emboli due to in vitro and in vivo studies on flow dynamics of bubbles in small vessels. Intensive research regarding the thromboinflammatory changes at the level of the endothelium has been described recently. The obstruction of vessels by air emboli causes immediate pathoanatomic and immunologic and thromboinflammatory responses at the level of the endothelium. In this review, we describe those immunologic and thromboinflammatory responses at the level of the endothelium as well as evaluate traditional and novel forms of therapy for this rare and often unrecognized clinical condition
Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies
Iatrogenic vascular air embolism is a relatively infrequent event but is associated with significant morbidity and mortality. These emboli can arise in many clinical settings such as neurosurgery, cardiac surgery, and liver transplantation, but more recently, endoscopy, hemodialysis, thoracentesis, tissue biopsy, angiography, and central and peripheral venous access and removal have overtaken surgery and trauma as significant causes of vascular air embolism. The true incidence may be greater since many of these air emboli are asymptomatic and frequently go undiagnosed or unreported. Due to the rarity of vascular air embolism and because of the many manifestations, diagnoses can be difficult and require immediate therapeutic intervention. An iatrogenic air embolism can result in both venous and arterial emboli whose anatomic locations dictate the clinical course. Most clinically significant iatrogenic air emboli are caused by arterial obstruction of small vessels because the pulmonary gas exchange filters the more frequent, smaller volume bubbles that gain access to the venous circulation. However, there is a subset of patients with venous air emboli caused by larger volumes of air who present with more protean manifestations. There have been significant gains in the understanding of the interactions of fluid dynamics, hemostasis, and inflammation caused by air emboli due to in vitro and in vivo studies on flow dynamics of bubbles in small vessels. Intensive research regarding the thromboinflammatory changes at the level of the endothelium has been described recently. The obstruction of vessels by air emboli causes immediate pathoanatomic and immunologic and thromboinflammatory responses at the level of the endothelium. In this review, we describe those immunologic and thromboinflammatory responses at the level of the endothelium as well as evaluate traditional and novel forms of therapy for this rare and often unrecognized clinical condition
Briefing paper on the role of psychology and psychologists in environmental hazard and disaster research, community preparedness, and disaster response
What does it mean to say that Aboriginal suicide is different? Differing cultures, accounts, and idioms of distress in the context of indigenous youth suicide
Colin Tatz's article provides a provocative and ostensibly 'different' perspective on indigenous suicide. There are multiple problems with the arguments and evidence presented, and the article, as a whole, is arguably more of a rhetorical 'argument' and ideological position and challenge than a research report, considered review of the theoretical or research literatures addressing this phenomenon, or substantive analysis of a critical and salient social problem. It should not be confused with a systematic, evidence and research findings-based study and/or evaluation ofthe evidence ofothers. Given the status of the author, the seriousness of the issue, and the social problem construction character of the public discussion to date, it is important that some counter views and caveats are offered, ideally from a spectrum of disciplinary, professional practice, and cross-cultural perspectives. Professional and 'research-based' analyses, accounts and evaluations have real consequences, not only in the context of prevention and intervention programs, policy initiatives and reviews, and funding in the health sector, but also with respect to public understandings of science and, in this case, health and prevention programs. The article and position offered by Tatz could well have unfortunate consequences with respect to prejudicial disciplinary and professional practice judgements, and the discounting of important and very necessary initiatives and programs at the level of preventive public health and individual and community intervention